AI assistant
Sending…
FATE THERAPEUTICS INC — Director's Dealing 2013
Oct 7, 2013
34091_dirs_2013-10-07_dc40fe5f-da91-4c9f-936e-e152488f34a5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FATE THERAPEUTICS INC (FATE)
CIK: 0001434316
Period of Report: 2013-10-04
Reporting Person: MENDLEIN JOHN (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-10-04 | Common Stock | P | 16667 | $6 | Acquired | 156774 | Direct |
More from FATE THERAPEUTICS INC
Interim / Quarterly Report
2026
May 13
Regulatory Filings
2026
May 13
Proxy Solicitation & Information Statement
2026
Apr 24
Annual Report
2026
Feb 26
Regulatory Filings
2026
Feb 26
Director's Dealing
2026
Jan 16
Director's Dealing
2026
Jan 16
Director's Dealing
2026
Jan 16
Director's Dealing
2026
Jan 12
Director's Dealing
2026
Jan 12